The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.

OBJECTIVES: To describe associations between different summaries of adherence in the first year on antiretroviral therapy (ART) and the subsequent risk of mortality, to identify patients at high risk because of early adherence behaviour. METHODS: We previously described an approach where adherence b...

Full description

Bibliographic Details
Main Authors:	Kiwuwa-Muyingo, S, Walker, A, Oja, H, Levin, J, Miiro, G, Katabira, E, Kityo, C, Hakim, J, Todd, J
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
by: Muyingo, S, et al.
Published: (2008)

Clustering based on adherence data.
by: Kiwuwa-Muyingo, S, et al.
Published: (2011)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial
by: Parikh, S, et al.
Published: (2013)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
by: Walker, A, et al.
Published: (2012)

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.
by: Kiwuwa-Muyingo, S, et al.
Published: (2013)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
by: Gomo, Z, et al.
Published: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
by: Lara, A, et al.
Published: (2012)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
by: Antonieta Medina Lara, et al.
Published: (2012-01-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
by: Inzaule, S, et al.
Published: (2016)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
by: Seth C Inzaule, et al.
Published: (2016-01-01)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
by: Mugyenyi, P, et al.
Published: (2010)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
by: Walker, A, et al.
Published: (2010)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
by: Seth C Inzaule, et al.
Published: (2017-01-01)

Group counselling for adherence support among young people failing first-line antiretroviral therapy in Zimbabwe
by: Bahati Kasimonje, et al.
Published: (2021-10-01)

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
by: Ssali, F, et al.
Published: (2006)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
by: Odere Mathew, et al.
Published: (2009-07-01)

Effect of justification of wife-beating on experiences of intimate partner violence among men and women in Uganda: A propensity-score matched analysis of the 2016 Demographic Health Survey data.
by: Damazo T Kadengye, et al.
Published: (2023-01-01)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
by: Jaganath, D, et al.
Published: (2014)

The impact of attending a behavioural intervention on HIV incidence in Masaka, Uganda.
by: Quigley, M, et al.
Published: (2004)

Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda.
by: Sheri D Weiser, et al.
Published: (2010-04-01)

Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda.
by: Samson Okello, et al.
Published: (2016-01-01)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
by: Nanzigu S, et al.
Published: (2013-12-01)

Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention
by: Celestino Obua, et al.
Published: (2014-06-01)

Adherence to antiretroviral therapy in Jinja, Uganda: a six-year follow-up study.
by: Martin Mbonye, et al.
Published: (2013-01-01)

Prevalence, correlates for early neurological disorders and association with functioning among children and adolescents with HIV/AIDS in Uganda
by: Richard Stephen Mpango, et al.
Published: (2019-01-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
by: Alexander Billioux, et al.
Published: (2015-01-01)

The Role of Mass Media Campaigns in Improving Adherence to Antiretroviral Therapy Among Adolescents Living with HIV in Southwestern Uganda
by: Akankunda S, et al.
Published: (2022-08-01)

Factors associated with HIV testing among youth in Tanzania based on the 2016-2017 Tanzania HIV Impact Survey (THIS).
by: Yan Wang, et al.
Published: (2022-01-01)

Factors associated with HIV testing among youth in Tanzania based on the 2016–2017 Tanzania HIV Impact Survey (THIS)
by: Yan Wang, et al.
Published: (2022-01-01)

Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals
by: Benjamin R Phelps, et al.
Published: (2010-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
by: Kityo, C, et al.
Published: (2014)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
by: Haberer, J, et al.
Published: (2011)

Free antiretrovirals must not be restricted only to treatment-naive patients. Experience in Uganda suggests that restricting access is not the way forward.
by: Robert Colebunders, et al.
Published: (2005-10-01)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
by: Kutamba Elizabeth, et al.
Published: (2010-05-01)

Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings
by: Jessica E. Haberer, et al.
Published: (2022-07-01)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
by: Christophe T Tchakoute, et al.
Published: (2022-01-01)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
by: Alexander J Szubert, et al.
Published: (2017-11-01)

Enabling data sharing and utilization for African population health data using OHDSI tools with an OMOP-common data model
by: Sylvia Kiwuwa-Muyingo, et al.
Published: (2023-06-01)

Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study
by: Twimukye, Adelline, et al.
Published: (2021-06-01)

Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
by: Herbert C Duber, et al.
Published: (2015-01-01)